Health Condition 1: null- Dysfunctional uterine bleeding
Conditions
Interventions
None listed
Sponsors
Kempegowda institute of medical sciences and research hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects between 20-50 years of age diagnosed as dysfunctional uterine bleeding. 2.Willingness to give written informed consent and availability for regular follow up.
Exclusion criteria
Exclusion criteria: 1. Subjects with pelvic pathologies such as uterine fibroids, endometriosis, endometrial polyps, PCOS and pelvic inflammatory disease. 2. Pregnant women or lactating women in the first 6 months of postnatal period, women who have had an abortion during the previous 3 months, IUCD or contraceptive pill users. 3. Presence of medical diseases like cardiac dysfunction, uncontrolled diabetes mellitus, uncontrolled hypertension, liver and renal dysfunction, migraine, thyroid disorders, cerebrovascular disease, past or present neoplastic diseases, thromboembolism and coagulation disorders. 4. Women on immunosuppressant therapy, anticoagulation therapy, or who have a known hypersensitivity to any of the drugs used in dysfunctional uterine bleeding. 5. Subjects who have participated in any clinical trial in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To determine the pattern of drug prescribing for women with DUB. 2. To evaluate the efficacy of the drugs used. 3. To assess the tolerability and compliance to the prescribed medications.Timepoint: All the subjects were followed up for a period of 3 months after the completion of drug therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the tolerability and compliance to the prescribed medications.Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Pavithra M S
Kempegowda institute of medical sciences, Bangalore
Outcome results
None listed